Fiona Day

Conjoint Associate Professor

Newcastle University

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Cancer Research Cancer Research professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Fiona Day is a Conjoint Associate Professor at The University of Newcastle, Australia. Her research focuses on oncology, particularly in smoking cessation practices and palliative treatments for esophageal and gastroesophageal cancers. She has contributed significantly to studies on the implementation of smoking cessation care and the role of circulating tumor DNA in guiding adjuvant therapy.

Articles (12)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (8)

Stephen Thompson

AUSTRALIA

View details

Jennifer Donnelly

Swinburne University of Technology

AUSTRALIA

View details

Timothy J. Price

AUSTRALIA

View details

Belinda Lee

Oncologist & Head of Cancer Clinical Trials Unit

AUSTRALIA

View details

Melissa McEnallay

University of Newcastle

AUSTRALIA

View details

James Lynam

Conjoint Associate Professor

University of Newcastle Australia

AUSTRALIA

View details

Daniel Barker

Conjoint Senior Lecturer

Newcastle University

AUSTRALIA

View details

Christine L Paul

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Fiona Day

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Smoking Cessation Practices in Australian Oncology Settings: A Cross‐Sectional Study of Who, How, and When

A Comparison of Australian Oncology Clinicians' Smoking Cessation Care Practices for People Who Currently Smoke Versus Those Who Report Recently Stopping Smoking

Esophageal chemoradiotherapy with concurrent nivolumab: Pilot results in the palliative treatment of oligometastatic disease

ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 in untreated metastatic pancreatic adenocarcinoma. An Australasian Gastro-Intestinal Trials Group (AGITG) trial

Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic oesophageal and gastrooesophageal carcinoma with dysphagia: a single arm phase II clinical trial (PALEO, sponsored by the Australasian Gastro-Intestinal Trials Group)

Building staff capability, opportunity, and motivation to provide smoking cessation to people with cancer in Australian cancer treatment centres: development of an implementation intervention framework for the Care to Quit cluster randomised controlled trial.

Phase I trial of hypofractionated chemoradiotherapy in the palliative management of esophageal and gastro-esophageal cancer

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer

Psychometric properties of leadership scales for health professionals: a systematic review

Care to Quit: a stepped wedge cluster randomised controlled trial to implement best practice smoking cessation care in cancer centres

Business as unusual: medical oncology services adapt and deliver during COVID‐19

Gastrostomy dependency trends over 15 years of patients at a large tertiary referral center following the insertion of a prophylactic gastrostomy for chemoradiation for mucosal head and neck cancer

Collaborators (8)

Stephen Thompson

Jennifer Donnelly

Timothy J. Price

Belinda Lee

Melissa McEnallay

James Lynam

Daniel Barker

Christine L Paul

Make your next move.